Trials / Terminated
TerminatedNCT04955951
Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic Dermatitis
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Ahram Canadian University · Academic / Other
- Sex
- Male
- Age
- 20 Years – 30 Years
- Healthy volunteers
- Not accepted
Summary
Non-atopic dermatitis (NAD) or eczema is a common inflammatory condition; potentially debilitating that can compromise quality of life. It is usually seen in childhood, but can onset within or persist into adulthood.
Detailed description
Polarized ultraviolet-free polychromatic light is used as therapeutic option for the treatment of wound healing and dermatological conditions. 40 male patients who had atopic dermatitis in the chronic stage, they were complaining from itching, inflammation and skin thickness in the arm, wrist, hand and leg will participate in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | polarized light | A Bioptron light therapy phototherapeutic device (Bioptron AG, Wollerau, Switzerland) with 5 cm treatment diameter (BIOPTRON MedAll®, 480-3400 nm, polarization level of 95%, power density 40 mW/cm2, energy density 2,4 J/cm2 per minute |
| DRUG | Topical corticosteroid ointment | corticosteroid 1 %. |
Timeline
- Start date
- 2021-07-01
- Primary completion
- 2021-09-15
- Completion
- 2022-01-15
- First posted
- 2021-07-09
- Last updated
- 2023-08-23
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04955951. Inclusion in this directory is not an endorsement.